Home › Drug Codes › Q Codes › Q5172 · Filkri
Updated October 1st, 2026

Filkri Q Code: Q5172

Injection, filgrastim-laha (filkri), biosimilar, 1 microgram

Medicare Payment Limit ?
Not published
CMS publishes none for Q4 2026
APC Payment Limit ?
$0.738
/ HCPCS billing unit · APC 0973
ASP ?
No current ASP
Not available for Q4 2026
WAC ?
$0.717
/ HCPCS billing unit
AWP ?
$0.86
/ HCPCS billing unit
NDCs Crosswalked ?
4
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, filgrastim-laha (filkri), biosimilar, 1 microgram
HCPCS Added Date October 1, 2026
Manufacturer Accord
Route of Administration Intravenous, Subcutaneous
Generic Status Single-Source; Branded
Dosage Form Injection, Solution

About Filkri

Filkri is a medication aligned to the HCPCS Q Code: Q5172 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology Colony Stimulating Factor drug administered via the intravenous or subcutaneous routes and manufactured by Accord.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Package Manufacturer HCPCS Units WAC AWP
69448-0008-03
300 MCG / 0.5 ML Filkri Intravenous Injection 300 MCG/0.5ML - 10 SYRINGE in 1 BOX (69448-008-03) / .5 mL in 1 SYRINGE
Accord BioPharma Inc., 3000 $2,150.00 $0.717 / unit $2,580.00 $0.86 / unit
69448-0008-63
300 MCG / 0.5 ML Filkri Intravenous Injection 300 MCG/0.5ML - 1 SYRINGE in 1 BOX (69448-008-63) / .5 mL in 1 SYRINGE
Accord BioPharma Inc., 300 $215.00 $0.717 / unit $258.00 $0.86 / unit
69448-0009-03
480 MCG / 0.8 ML Filkri Intravenous Injection 480 MCG/0.8ML - 10 SYRINGE in 1 BOX (69448-009-03) / .8 mL in 1 SYRINGE
Accord BioPharma Inc., 4800 $3,450.00 $0.719 / unit $4,140.00 $0.863 / unit
69448-0009-63
480 MCG / 0.8 ML Filkri Intravenous Injection 480 MCG/0.8ML - 1 SYRINGE in 1 BOX (69448-009-63) / .8 mL in 1 SYRINGE
Accord BioPharma Inc., 480 $345.00 $0.719 / unit $414.00 $0.863 / unit

Effective 10/1/26 (WAC & AWP)

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

Filkri Pricing & Reimbursement

Historical Graphing and Billing Calculator

HCPCS Units
%
Common:

Estimates only. Payer reimbursement varies by contract, site of care, and sequestration.

Estimated Reimbursement

Filgrastim Biosimilar Information:

Filkri Approval Date: January 15, 2026

Product Name HCPCS Code Active Ingredient BLA Type
Neupogen J1442 Filgrastim 351(a) Originator Product
Zarxio Q5101 Filgrastim 351(k) Biosimilar
Nivestym Q5110 Filgrastim 351(k) Biosimilar
Releuko Q5125 Filgrastim 351(k) Biosimilar
Nypozi Q5148 Filgrastim 351(k) Biosimilar
Filkri Q5172 Filgrastim 351(k) Biosimilar

Filkri CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96372 Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

Filkri Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Acute myeloid leukemia Hematopoietic syndrome of acute radiation syndrome Nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs Nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation Severe chronic neutropenia
Drug Class
Granulocyte Colony-Stimulating Factor [CS]Increased Myeloid Cell Production [PE]Leukocyte Growth Factor [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Filkri billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for Filkri.
Are there any available Filkri patient assistance programs?
Our team has not identified a manufacturer-published source of patient assistance information for Filkri.
Where can I find Filkri prescribing information?
Filkri prescribing information can be found at the link below. Please reach out to us if you believe this information to be inaccurate or out of date. Visit Here →
Where can I find Filkri side effect information?
Our team has not yet identified a source of side effects information for Filkri. Please check back in a few weeks.
Does billing Filkri require JZ/JW wastage modifiers?
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.